Nathan White, CPC

23 Followers

14 SlideShares 23 Followers 20 Folgens

14 SlideShares 23 Followers 20 Folgens

In this increasingly cost-conscious drug development and commercialisation environment, value is at the forefront of the minds of patients, payers, HCP's, and policymakers. ICON's Access, Commercialisation & Communications (ACC) integrated team of industry experts provide life-science clients with strategic guidance and workable tactical solutions to support commercial success around the globe. ACC’s seamless integration of pricing, HEOR, publication/value communication, reimbursement, market access, HTA, patient insights and creative services efficiently delivers cross-functional customized solutions that drive the commercial success of our clients’ products.

market access payers reimbursement contracting health economics heor pricing specialty pharmacy pharma rems policy marketing pharmaceuticals iconplc pmc fdama payor rwe fda health policy biotech bio ppcac healthcare reform inventiv health reimbursem

Aktivität
Info

Fda Cms Summit Panel Preso In Ventiv

Vor 13 Jahren • 329 Aufrufe

Poster Presented at ISMPP, April 2010

Vor 13 Jahren • 211 Aufrufe

BIOTECH 2011 NJ/PA/DE Case Studies

Vor 12 Jahren • 221 Aufrufe

WEBINAR: Developing Payer Evidence: The Role of Post Approval Programs

Vor 12 Jahren • 705 Aufrufe

BIO Windhover Pharmaceutical Strategic Alliances Conference April 2011

Vor 12 Jahren • 476 Aufrufe

340 b coalition presentation

Vor 12 Jahren • 195 Aufrufe

BIOTECH 2011 NJ/DE/PA Case studies

Vor 12 Jahren • 394 Aufrufe

BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAP

Vor 12 Jahren • 910 Aufrufe

CMAC 2011 Presentation

Vor 12 Jahren • 589 Aufrufe

EBI inVentiv Market Access Virtual Conference

Vor 12 Jahren • 1084 Aufrufe

F5 Outcomes based contracting 040416 ARSmm

Vor 7 Jahren • 608 Aufrufe

What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance on Communication of Healthcare Economic Information

Vor 7 Jahren • 498 Aufrufe

WHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance on Communication of Healthcare Economic Information

Vor 7 Jahren • 580 Aufrufe

The Rise of Value-Based Contracting for Biopharmaceuticals and Medical Technologies

Vor 6 Jahren • 218 Aufrufe

In this increasingly cost-conscious drug development and commercialisation environment, value is at the forefront of the minds of patients, payers, HCP's, and policymakers. ICON's Access, Commercialisation & Communications (ACC) integrated team of industry experts provide life-science clients with strategic guidance and workable tactical solutions to support commercial success around the globe. ACC’s seamless integration of pricing, HEOR, publication/value communication, reimbursement, market access, HTA, patient insights and creative services efficiently delivers cross-functional customized solutions that drive the commercial success of our clients’ products.

market access payers reimbursement contracting health economics heor pricing specialty pharmacy pharma rems policy marketing pharmaceuticals iconplc pmc fdama payor rwe fda health policy biotech bio ppcac healthcare reform inventiv health reimbursem